Waterloo, Ontario, March 17, 2016 – Intellijoint Surgical Inc., a privately held Canadian medical technology company committed to developing and commercializing miniaturized surgical smart tools announced today the signing of a distribution agreement with Corin Group. The deal gives Corin distribution rights for Intellijoint’s flagship product, intellijoint HIP™, in Australia and paves the way for broader distribution and co-development between the two companies.
intellijoint HIP provides surgeons with vital intraoperative measurements in real time, enabling proper establishment of cup position, equalization of leg length and restoration of hip offset. These critical measurements enable surgeons and hospitals to improve surgical outcomes by reducing uncertainty and risk, while improving patient outcomes and economics.
Russ Mably, Corin’s Chief Operating Officer commented, “We are delighted to partner with such a progressive company as Intellijoint Surgical, and are excited about our future collaboration. This partnership will further strengthen our market leading position in functional implant positioning with our existing OPS Technology (Optimized Positioning System), and underlines our commitment to continue to invest in Personalized Procedural Innovation”.
“We are pleased to partner with Corin to offer intellijoint HIP to surgeons in Australia. The broader capability of Corin’s organization and their commitment to innovation will expand access to the latest technology available for 3D surgical measurement to the growing Australian hip replacement market where surgeons currently perform about 45,000 procedures annually. We look forward to the beginning of a meaningful relationship between our two companies and are excited about future opportunities,” says Armen Bakirtzian, Chief Executive Officer and Co-founder of Intellijoint Surgical.
Intellijoint Surgical is a Waterloo-based innovative medical technology company. Founded in 2010, they develop and commercialize miniaturized surgical smart tools that enhance surgeon accuracy, increase hospital economic efficiencies, and improve patient outcomes. The company’s R&D team is led by the former co-founder of Medtronic’s computer assisted surgery division, and driven by a team of renowned orthopaedic surgeons: Drs. Allan Gross and David Backstein in Toronto, Dr. Wayne Paprosky in Chicago, Dr. Javad Parvizi in Philadelphia and Drs. Michael Cross and Ran Schwarzkopf in New York.
About Corin Group
As a leader in orthopaedic innovation, Corin has pioneered a number of landmark developments since it was founded in 1985. Corin is very proud to have been able to improve the quality of life of hundreds of thousands of patients around the world through the introduction of these groundbreaking products, and believes that this heritage distinguishes Corin within the global orthopaedic market. Corin’s talented and dedicated teams share a common commitment – to deliver quality orthopaedic products, procedural innovation technologies and services to patients, surgeons and healthcare providers, which exceed their expectations and positively impact their lives, through Responsible Innovation.